Author

Correia CH

Ecole Polytechnique Federale de Lausanne - Cited by 5,577 - Bioengineering - Protein Design

Biography

Throughout my PhD and postdoctoral studies I was trained in world-renowned laboratories and institutions in the United States of America (University of Washington and The Scripps Research Institute). Very early in my scientific career I found out my fascination about protein structure and function. My PhD studies evolved in the direction of immunogen design and vaccine engineering which sparked my interest in the many needs and opportunities in vaccinology and translational research. 
Title
Cited by
Year
Macromolecular modeling and design in Rosetta: recent methods and frameworks
JK Leman, BD Weitzner, SM Lewis, J Adolf-Bryfogle, N Alam, RF Alford, ...Nature methods 17 (7), 665-680, 2020202
391
2020
Scaffolding protein functional sites using deep learning
J Wang, S Lisanza, D Juergens, D Tischer, JL Watson, KM Castro, ...Science 377 (6604), 387-394, 2022202
111
2022
Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learning
DM Mason, S Friedensohn, CR Weber, C Jordi, B Wagner, SM Meng, ...Nature Biomedical Engineering 5 (6), 600-612, 2021202
109
2021
Fast end-to-end learning on protein surfaces
F Sverrisson, J Feydy, BE Correia, MM BronsteinProceedings of the IEEE/CVF Conference on Computer Vision and Pattern …, 2021202
72
2021
Bottom-up de novo design of functional proteins with complex structural features
C Yang, F Sesterhenn, J Bonet, EA van Aalen, L Scheller, LA Abriata, ...Nature Chemical Biology 17 (4), 492-500, 2021202
64
2021
Antibodies to combat viral infections: development strategies and progress
G Pantaleo, B Correia, C Fenwick, VS Joo, L PerezNature Reviews Drug Discovery 21 (9), 676-696, 2022202
37
2022
Equivariant 3d-conditional diffusion models for molecular linker design
I Igashov, H Stärk, C Vignac, VG Satorras, P Frossard, M Welling, ...arXiv preprint arXiv:2210.05274, 2022202
25
2022
Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein
MD Hoffmann, J Mathony, J Upmeier zu Belzen, Z Harteveld, ...Nucleic acids research 49 (5), e29-e29, 2021202
23
2021
Structure-based drug design with equivariant diffusion models
A Schneuing, Y Du, C Harris, A Jamasb, I Igashov, W Du, T Blundell, P Lió, ...arXiv preprint arXiv:2210.13695, 2022202
19
2022
Computational design of novel protein–protein interactions–An overview on methodological approaches and applications
A Marchand, AK Van Hall-Beauvais, BE CorreiaCurrent Opinion in Structural Biology 74, 102370, 2022202
19
2022
A rational blueprint for the design of chemically-controlled protein switches
S Shui, P Gainza, L Scheller, C Yang, Y Kurumida, S Rosset, S Georgeon, ...Nature communications 12 (1), 5754, 2021202
18
2021
Computational design of anti-CRISPR proteins with improved inhibition potency
J Mathony, Z Harteveld, C Schmelas, J Upmeier zu Belzen, ...Nature chemical biology 16 (7), 725-730, 2020202
17
2020
Modeling immunity with rosetta: Methods for antibody and antigen design
CT Schoeder, S Schmitz, J Adolf-Bryfogle, AM Sevy, JA Finn, MF Sauer, ...Biochemistry 60 (11), 825-846, 2021202
15
2021
A nanoscaffolded spike-RBD vaccine provides protection against SARS-CoV-2 with minimal anti-scaffold response
D Lainšček, T Fink, V Forstnerič, I Hafner-Bratkovič, S Orehek, Ž Strmšek, ...Vaccines 9 (5), 431, 2021202
12
2021
Oligomerization profile of human transthyretin variants with distinct amyloidogenicity
A Frangolho, BE Correia, DC Vaz, ZL Almeida, RMM BritoMolecules 25 (23), 5698, 2020202
11
2020
Physics-informed deep neural network for rigid-body protein docking
F Sverrisson, J Feydy, J Southern, MM Bronstein, BE CorreiaMLDD workshop of ICLR 2022, 2022202
10
2022
De novo design of protein interactions with learned surface fingerprints
P Gainza, S Wehrle, A Van Hall-Beauvais, A Marchand, A Scheck, ...Nature, 1-, 2023202
9
2023
Immune response to vaccine candidates based on different types of nanoscaffolded RBD domain of the SARS-CoV-2 spike protein
D Lainšček, T Fink, V Forstnerič, I Hafner-Bratkovič, S Orehek, Ž Strmšek, ...bioRxiv, 2020.08. 28.24426, 2020202
9
2020
Assessing and enhancing foldability in designed proteins
D Listov, R Lipsh‐Sokolik, S Rosset, C Yang, BE Correia, SJ FleishmanProtein Science 31 (9), e4400, 2022202
8
2022
A generic framework for hierarchical de novo protein design
Z Harteveld, J Bonet, S Rosset, C Yang, F Sesterhenn, BE CorreiaProceedings of the National Academy of Sciences 119 (43), e2206111119, 2022202
7
2022

Referred From: https://scholar.google.com/citations?user=Va246xYAAAAJ&hl&hl=en&oi=ao

Cited by
Citations 5577
h-index 31
i10-index 49
Open Access Journals